Another medication in the works is dapiglutide, a blend of GLP-1 and GLP-2 agonists, and there are more therapies coming down the pike
Watch on YouTube
doi: 10.1210/en.2007-1292 Summary Keywords GLP-1, DPP-4, fracture, diabetes, bone, osteoporosis, antidiabetic, glucose-lowering drugs Citation Al-Mashhadi ZK, Viggers R, Fuglsang-Nielsen R, Vestergaard P, Gregersen S and Starup-Linde J (2022) The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
Appetite suppression and reduced fluid intake People on semaglutide eat less
To initiate a return, please reach out to our Customer Support team at [email protected]
Better blood sugar control